Choroid Plexectomy for Hydrocephalus Management in a Pediatric Patient with a Pilocytic Astrocytoma

Reagan A Collins1, Brittany Tu1, Laszlo Nagy1

  • 1Department of Pediatrics, Texas Tech University Health Sciences Center, Lubbock, Texas, United States.

Insights

Choroid plexectomy offers a shunt-independent solution for hydrocephalus in immunocompromised patients. This surgical option can prevent recurrent infections often associated with traditional shunt placements.

Area of Science:

  • Neurosurgery
  • Pediatric Neurology
  • Oncology

Background:

  • Hydrocephalus management, particularly in pediatric cases, often involves cerebrospinal fluid (CSF) shunting.
  • Recurrent infections and shunt failures are significant challenges, especially in immunocompromised patients.
  • Pilocytic astrocytoma can lead to hydrocephalus requiring complex management strategies.

Observation:

  • A 2-year-old with hydrocephalus secondary to pilocytic astrocytoma presented with symptoms of shunt malfunction.
  • The patient had a history of multiple shunt revisions and chemotherapy-induced neutropenia, increasing infection risk.
  • The patient underwent choroid plexus coagulation and resection.

Findings:

  • Following choroid plexectomy, the patient achieved shunt independence.
  • The patient met neurodevelopmental milestones three years post-procedure.
  • Choroid plexectomy demonstrated efficacy in managing hydrocephalus without shunt-related complications.

Implications:

  • Choroid plexectomy should be considered as an alternative to shunting for hydrocephalus, particularly in immunocompromised pediatric patients.
  • This approach may reduce the incidence of shunt-related infections and revisions.
  • Further research into choroid plexectomy for complex hydrocephalus cases is warranted.